№1
Empagliflozin mitigates type 2 diabetes‐associated peripheral neuropathy: a glucose‐independent effect through AMPK signaling
Noha F. Abdelkader, Marawan A. Elbaset, Passant E. Moustafa, Sherehan M. Ibrahim
DOI: 10.1007/s12272-022-01391-5
9-29
№2
Modern possibilities of effective nephroprotection in patients with diabetes
Cherenko M. S.
30-37
№4
Conference with international participation
«Topics of modern diabetology»: conference update
40-42
№5
Road map of a patient with type 2 diabetes
Mankovsky B. M., Sayenko Ya. A
DOI: https://doi.org/10.57105-2415-7252-2022-5-05
43-47
№7
Prescription algorithm for hypoglycemic medications for the patients with type 2 diabetes
Sayenko Ya. A.
50-53
№9
Possibilities of prevention and treatment of cognitive dysfunction in people with diabetes
Mankovsky B. M.
59-71